Cross Reactive Cellular Immune Response to HCV Genotype 1 and 4 Antigens among Genotype 4 Exposed Subjects

• Iman F. Galal,

  Affiliation Egyptian Company for Blood Transfusion Services (Egyblood)/VACSERA; Agouza, Giza, Egypt

  ⨯
• Zainab Zakaria,

  Affiliation Egyptian Company for Blood Transfusion Services (Egyblood)/VACSERA; Agouza, Giza, Egypt

  ⨯
• Walaa R. Allam,

  Affiliation Egyptian Company for Blood Transfusion Services (Egyblood)/VACSERA; Agouza, Giza, Egypt

  ⨯
• Mohamed A. Mahmoud,

  Affiliation Department of Hepatology, National Liver Institute, Menoufiya University, Menoufiya, Egypt

  ⨯
• Ahmed R. Ezzat,

  Affiliation Department of Zoology, Faculty of Science, Ain Shams University, Cairo, Egypt

  ⨯
• Ahmed Osman,

  Affiliation Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo

  ⨯
• Imam Waked,

  Affiliation Department of Hepatology, National Liver Institute, Menoufiya University, Menoufiya, Egypt

  ⨯
• G. Thomas Strickland,

  Affiliation Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Sayed F. Abdelwahab

  * E-mail: sayed.awahab@mu.edu.eg

  Affiliations Egyptian Company for Blood Transfusion Services (Egyblood)/VACSERA; Agouza, Giza, Egypt, Department of Microbiology and Immunology, Faculty of Medicine, Minia University, Minia, Egypt

  ⨯